Podcast: US Fed keeps interest rates unchanged, forecasts 3 cuts in 2024; IRCTC, NBCC in focus, & more | Market Minutes
Pharma stocks have been the absolute darlings of the market for months now. But is all the good news in the price now? – Part 2
Pharma stocks have been the absolute darlings of the market for months now. But is all the good news in the price now? – Part 1
Would not chase the US focused generic pharma stocks higher. They are at best hiding places with low RoEs. Its more like a 1-year tactical trade.
